Imagion Biosystems logo

IBX - Imagion Biosystems Share Price

A$0.092 0.0  12.2%

Last Trade - 14/05/21

Small Cap
Market Cap £50.5m
Enterprise Value £43.6m
Revenue £276k
Position in Universe 936th / 1911
Unlock IBX Revenue
Relative Strength (%)
1m -33.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -59.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.34 0.37 0.43 0.50
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ImagionBiosystems Ltd revenues increased 16% to A$501K. Net lossincreased 56% to A$5.4M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Higher net loss reflects Sharebased payments expense increase from A$941K (income) toA$399K (expense), Research and development costs increaseof 26% to A$2.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


IBX Revenue Unlock IBX Revenue

Net Income

IBX Net Income Unlock IBX Revenue

Normalised EPS

IBX Normalised EPS Unlock IBX Revenue

PE Ratio Range

IBX PE Ratio Range Unlock IBX Revenue

Dividend Yield Range

IBX Dividend Yield Range Unlock IBX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
IBX EPS Forecasts Unlock IBX Revenue
Profile Summary

Imagion Biosystems Limited is an Australia-based is engaged in the business of research and development of medical imaging technology through its wholly owned subsidiary, Imagion Biosystems Inc. The Company is focused on the research and development of the MagSense SPMR technology. The Company's technologies include MagSense technology and PrecisionMRX nanoparticles. MagSense technology differentiates benign from malignant tumors since the antibody-conjugated nanoparticles only bind to the targeted tumor cells. MagSense instrument uses sensitive magnetic field sensors to detect the remnant magnetic relaxation of the injected nanoparticles. MagSense nanoparticles are supplied as an injectable solution and formulated to provide delivery to specific types of cancer cells. PrecisionMRX nanoparticles are characterized superparamagnetic nanoparticles. The Company serves a range of applications, including detecting cancer, monitoring therapy and detecting other diseases.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated December 6, 2016
Public Since June 22, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Australian Stock Exchange - SEATS
Shares in Issue 998,367,288
Free Float (0.0%)
Eligible for
IBX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for IBX
Upcoming Events for IBX
Thursday 22nd July, 2021 Estimate
Imagion Biosystems Ltd Annual Shareholders Meeting
Frequently Asked Questions for Imagion Biosystems
What is the Imagion Biosystems share price?

As of 14/05/21, shares in Imagion Biosystems are trading at A$0.092, giving the company a market capitalisation of £50.5m. This share price information is delayed by 15 minutes.

How has the Imagion Biosystems share price performed this year?

Shares in Imagion Biosystems are currently trading at A$0.092 and the price has moved by 0.318k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Imagion Biosystems price has moved by 0.213k% over the past year.

What are the analyst and broker recommendations for Imagion Biosystems?

There are no analysts currently covering Imagion Biosystems.

When will Imagion Biosystems next release its financial results?

Imagion Biosystems is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Imagion Biosystems dividend yield?

Imagion Biosystems does not currently pay a dividend.

Does Imagion Biosystems pay a dividend?

Imagion Biosystems does not currently pay a dividend.

When does Imagion Biosystems next pay dividends?

Imagion Biosystems does not currently pay a dividend.

How do I buy Imagion Biosystems shares?

To buy shares in Imagion Biosystems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Imagion Biosystems?

Shares in Imagion Biosystems are currently trading at A$0.092, giving the company a market capitalisation of £50.5m.

Where are Imagion Biosystems shares listed? Where are Imagion Biosystems shares listed?

Here are the trading details for Imagion Biosystems:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: IBX
What kind of share is Imagion Biosystems?

Based on an overall assessment of its quality, value and momentum, Imagion Biosystems is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Imagion Biosystems share price forecast 2021?

We were not able to load any forecast data for Imagion Biosystems.

How can I tell whether the Imagion Biosystems share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Imagion Biosystems. Over the past six months, the relative strength of its shares against the market has been -15.02%. At the current price of A$0.092, shares in Imagion Biosystems are trading at -24.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Imagion Biosystems PE Ratio?

We were not able to find PE ratio data for Imagion Biosystems.

Who are the key directors of Imagion Biosystems?

We were unable to find the directors for Imagion Biosystems.

Who are the major shareholders of Imagion Biosystems?

Here are the top five shareholders of Imagion Biosystems based on the size of their shareholding:

Board of Regents of The University of Texas System Corporation
Percentage owned: 1.01% (10.5m shares)
Faillace (Anthony Louis) Individual Investor
Percentage owned: 1% (10.4m shares)
Li (Haojie) Individual Investor
Percentage owned: 0.95% (9.85m shares)
G & D Finn Pty. Ltd. Corporation
Percentage owned: 0.77% (8.00m shares)
Lazaridis (Anestis) Individual Investor
Percentage owned: 0.73% (7.58m shares)
Similar to IBX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.